Hidradenitis Suppurativa Care: Key Insights from 2026 Conference
Experts discuss the importance of managing comorbidities and wound care in treating Hidradenitis Suppurativa.
High rates of depression and suicide are linked to Hidradenitis Suppurativa.
Comorbidity screenings are essential for effective patient management.
Innovative wound care techniques are critical for patient recovery.
At the recent 2026 Fall Clinical Dermatology Conference held in Las Vegas, Dr. Hamzavi emphasized the critical need for healthcare providers to build trust with patients suffering from Hidradenitis Suppurativa (HS). He noted that HS is associated with one of the highest suicide rates in dermatology, highlighting the importance of understanding patient experiences and anticipating their needs to foster rapport and trust.
Dr. Hamzavi discussed the significance of comprehensive comorbidity screening as part of the anticipatory care approach. He shared an initiative where patients receive a handout to share with their primary care physicians, detailing necessary screenings for conditions such as type 2 diabetes, cardiovascular risks, and mental health issues. This proactive strategy aims to address the multifaceted health challenges faced by HS patients.
The session also focused on the integration of newer therapies and the management of their side effects. Dr. Hamzavi pointed out that wound care remains an overlooked aspect of dermatology training. At Henry Ford, a specialized wound care nurse instructs patients on selecting appropriate dressings and tapes that minimize skin damage while effectively managing wounds associated with HS.
Procedural interventions, such as laser hair removal and local excision, were highlighted as vital components of a comprehensive treatment plan. These procedures can effectively address persistent draining tunnels in sensitive areas, while systemic therapies help control the disease in other regions. This dual approach allows for a more targeted focus on preventing new lesions and improving overall patient outcomes.
Looking ahead, the emphasis on patient education and innovative treatment strategies will be crucial in enhancing care for those affected by Hidradenitis Suppurativa. As the field evolves, ongoing research and collaboration among specialists will play a pivotal role in addressing the complex needs of these patients.
